“Hooking method” for hepatic inflow control: a new approach for laparoscopic Pringle maneuver

Table 1 Basic clinical characteristics and operation results of 17 patients

Case	Age	Sex	Liver cirrhosis	Tumor location	Surgical history	Surgical procedure	Occlusion time (min)	Blood loss (ml)	Operation time (min)	AST (U/L)	ALT (U/L)	Complications	POHS (days)	Pathology
1	73	M	Y	S2 + S7	LH	S2 + S7 NAH	13	200	312	521	493		11	HCC
2	44	M	Y	S6	-	S6 NAH	20	200	112	138	88		5	HCC
3	70	F	N	S2 + S3	LC	S2 + S3 AH	12	50	130	104	154		4	HCC
4	47	M	Y	S6	-	S6 NAH	23	200	220	170	128		6	HCC
5	53	M	Y	S5 + S6	-	S5 + S6 AH	35	200	250	298	256		5	HCC
6	65	M	N	S5	LH	S5 NAH	60	100	271	142	175		6	HCC
7	53	M	Y	S4	-	S4 AH	45	200	265	281	224	Pulmonary infection	14	HCC
8	55	F	Y	S6	-	S6 NAH	16	50	160	170	144		4	HCC
9	60	M	N	S6	-	S6 NAH	20	100	190	391	344		5	Hemangioma
10	60	M	Y	S5 + S8	-	S5 + S8 AH	60	200	323	722	682		6	HCC
11	57	M	Y	S4 + S6	LC	S4 AH + S6 NAH	60	300	248	652	406	Pleural effusion	5	MLC
12	53	M	Y	S2	-	S2 NAH	15	20	95	295	210		7	cHCC-CC
13	53	F	N	S2 + S3 + S4	-	S2 + S3 + S4 AH	14	300	295	378	310		5	Benign
14	55	M	Y	S3	-	S3 NAH	34	100	173	506	468		7	HCC
15	65	M	N	S8	-	S8 NAH	60	100	182	446	407		6	HCC
16	82	M	N	S4	-	S4 NAH	47	50	170	232	239		6	HCC
17	74	M	Y	S5	-	S5 NAH	40	100	170	271	181		10	HCC
Median (range)/mean ± SD^a	60 ± 10						34 (12–60)	145 ± 86	210 ± 70	336 ± 183	289 ± 159		6 (4–14)

F female, M male, Y yes, N no, LH laparoscopic hepatectomy, LC laparoscopic cholecystectomy, NAH non-anatomical hepatectomy, AH anatomical hepatectomy, AST aspartate transaminase, ALT alanine aminotransferase, POHS postoperative hospital stay, HCC hepatocellular carcinoma, MLC metastatic liver cancer, cHCC-CC combined hepatocellular cholangiocarcinoma
^aNormally distributed data were expressed as mean ± standard deviation (SD); skewed data were expressed as median (range)

ISSN: 1477-7819